Free standard shipping over $50 — US, Canada, Mexico and Europe
Ponyon
PT-141 (Bremelanotide)  10mg×10vials

PT-141 (Bremelanotide) 10mg×10vials

by Ponyon

PT-141 (Bremelanotide) is a synthetic cyclic peptide and melanocortin receptor agonist studied for its role in melanocortin signaling, neuroendocrine regulation, and central nervous system pathways associated with sexual behavior.

$64.00

$64.00 / serving

In stock
1

SKU PT141BRE-10MG_1 · 30-day returns

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide associated with the melanocortin signaling system. Research on PT-141 focuses on its activity at melanocortin receptors, particularly pathways involving MC3R and MC4R.

In life science research, PT-141 is investigated to better understand melanocortin receptor activation, neuroendocrine signaling, central nervous system regulation, and mechanisms associated with sexual behavior and reproductive biology. Its research profile is particularly associated with central melanocortin signaling pathways rather than primarily peripheral vascular mechanisms.

Research-grade PT-141 may be used in receptor pharmacology, neuroscience, endocrinology, and related life science studies.

Reviews

No reviews yet

Be the first to review this product.

Complete your routine

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before use if you are pregnant, nursing, taking medication or have a medical condition.

PT-141 (Bremelanotide) 10mg×10vials · Ponyon